Magtrace

SUSPENDED · PHASE2 · Ductal Carcinoma in Situ

Major protocol revision involving eligibility criteria and screening procedures in progress

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.